Provided by Tiger Trade Technology Pte. Ltd.

Mesoblast

15.13
+0.26001.75%
Post-market: 15.12-0.0100-0.07%19:44 EDT
Volume:215.70K
Turnover:3.25M
Market Cap:1.96B
PE:-34.08
High:15.28
Open:14.95
Low:14.83
Close:14.87
52wk High:21.50
52wk Low:13.05
Shares:129.69M
Float Shares:84.12M
Volume Ratio:1.17
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4440
EPS(LYR):-0.4441
ROE:-9.86%
ROA:-4.11%
PB:3.45
PE(LYR):-34.07

Loading ...

Mesoblast Wins FDA Nod for Registrational Ryoncil Trial in Duchenne Muscular Dystrophy

TIPRANKS
·
Apr 08

Mesoblast Ltd - FDA Clears Ryoncil Ind for Registration Trial in Dmd

THOMSON REUTERS
·
Apr 08

Mach Natural Resources, Mesoblast And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Benzinga_recent_news
·
Apr 07

Mesoblast Plans New Share Issue to Raise Capital

TIPRANKS
·
Apr 07

BRIEF-Mesoblast Says Ryoncil's Net Revenue For Quarter Increases To US$30.3M

Reuters
·
Apr 07

Mesoblast reports March quarter Ryoncil sales of $30.3M

TIPRANKS
·
Apr 07

Ryoncil® Continues Successful First Year Launch with Net Sales of US$30.3M in March Quarter

GlobeNewswire
·
Apr 07

Mesoblast Ltd - Ryoncil Net Revenue for Quarter Increases to US$30.3M

THOMSON REUTERS
·
Apr 07

Mesoblast Earnings Call: Ryoncil Momentum, Pipeline Upside

TIPRANKS
·
Mar 27

Mesoblast CEO Granted Additional Options Following Shareholder Approval

TIPRANKS
·
Mar 20

Mesoblast Issues 3.25 Million Unquoted Options Under Employee Incentive Scheme

TIPRANKS
·
Mar 20

Mesoblast Sets Inaugural R&D Day to Showcase Strategy, Ryoncil and Pipeline

TIPRANKS
·
Mar 18

Mesoblast Discloses Director Gregory George’s Share and ADS Purchases in Early March 2026

TIPRANKS
·
Mar 13

Dr. Teresa Montagut Appointed as Clinical Development and Medical Affairs Head at Mesoblast

GlobeNewswire
·
Mar 12

Mesoblast hires Regeneron veteran to lead clinical development and medical affairs

TIPRANKS
·
Mar 12

Mesoblast Director Gregory George Deepens Stake with US$16.4m Share Purchases

TIPRANKS
·
Mar 10

Cynata Therapeutics' Drug Candidate's Potential Reinforced by Mesoblast Results, Says Euroz Hartleys

MT Newswires Live
·
Mar 09